Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?

Although no statistically significant differences were found in prescription opioid safety measures between study arms, improvement in these measures during the comparison period for both study arms suggested that there may have events outside the trial, such as published revised Center for Disease Control and Prevention clinical practice guidelines for prescribing opioids, that may have impacted study outcomes.

Authors

Institutions

Publication Details

Journal
AJPM Focus
Published
2025-05-26
DOI
https://doi.org/10.1016/j.focus.2025.100371
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?

Trevor Baker, Nicole Mack, Emmanuel Oga, Svetla Slavova et al.
AJPM Focus
Opioid Use Disorder Treatment
article

Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?

Trevor Baker, Nicole Mack, Emmanuel Oga, Svetla Slavova, Dawn Goddard‐Eckrich, Charles Knott, Bridget Freisthler, Daniel P. Alford, SHARON L. WALSH, Donna Beers, Jennifer Bhuiyan, Derek Blevins, Daniel J. Feaster, Denise C. Babineau, Jennifer Villani, Adrienne Matson, Patricia Rippetoe Freeman, Jeffrey H. Samet, Gary A. Zarkin, Naleef Fareed, Douglas R. Oyler, James L. David, Edward V. Nunes, Joëlla W. Adams, LaShawn Glasgow, Abigail B. Shoben, Monica Roberts, FRANCES RUDNICK LEVIN, Shoshana N. Benjamin, Trang Quynh Nguyen, Frank Mierzwa, Laura Stinson, Daniel M. Walker, Nabila El‐Bassel, Netrali Dalvi, Lauren D’Costa, Aimee Shadwick, John Winhusen, Yi Han, Lisa Newman, Timothy Hunt, Rebecca D. Jackson, Redonna K. Chandler, Mallory Harris
article en

Abstract

Although no statistically significant differences were found in prescription opioid safety measures between study arms, improvement in these measures during the comparison period for both study arms suggested that there may have events outside the trial, such as published revised Center for Disease Control and Prevention clinical practice guidelines for prescribing opioids, that may have impacted study outcomes.

AJPM FocusVol. 4(6)
Boston University (US), Boston Medical Center (US), New York State Department of Health (US), National Institute on Drug Abuse (US), Massachusetts Department of Public Health (US), University of Kentucky (US), University of Miami (US), RTI International (US), The Ohio State University (US), Columbia University (US), University of Cincinnati Medical Center (US)
National Institutes of Health
Zero hunger
Openalex Percentile: Top 84%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.